Monoclonal antibody L9LS prevents malaria infection in adults
1. In this small phase one clinical trial, L9LS administration protected healthy adults from contracting a malarial infection. 2. No ...
1. In this small phase one clinical trial, L9LS administration protected healthy adults from contracting a malarial infection. 2. No ...
1. Compared to lower dose primaquine, higher dose primaquine had higher efficacy in preventing relapse of Plasmodium vivax malaria. 2. ...
1. Chlorfenapyr LLINs provided significantly better protection than pyriproxyfen and piperonyl-butoxide subtypes. 2. Chlorfenapyr LLINs costed an additional $19 US ...
1. In children, the use of mosquito nets for malaria control in early childhood was shown to be associated with ...
1. Vaccine efficacy at 6 months for R21/MM was 74% in group 1 and 77% in group 2. 2. R21/MM showed ...
1. Vaccine efficacy at 6 months for R21/MM was 74% in group 1 and 77% in group 2. 2. R21/MM ...
1. Targeted IRS was non-inferior to standard IRS with respect to malaria incidence (1.05 cases per 1000 person-years vs. 0.95 ...
1. Malaria case incidence was decreased in the intervention group (1.43 per child-year) compared to the control group (2.29 per ...
1. Targeted IRS was non-inferior to standard IRS with respect to malaria incidence (1.05 cases per 1000 person-years vs. 0.95 ...
1. Dihydroartemisinin-piperaquine was shown to prevent deaths of children with severe anemia in areas with intense malaria transmission compared to ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.